Clinical trial
A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.
NCT00323635 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 30, 2006
- Completion date
- January 31, 2011
- Enrollment
- 19 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.